Le Beau MM - Search Results

1

t(1;3)(p36;p21) is a recurring therapy-related translocation.

Sato Y, Izumi T, Kanamori H, Davis EM, Miura Y, Larson RA, Le Beau MM, Ozawa K, Rowley JD. Sato Y, et al. Among authors: le beau mm. Genes Chromosomes Cancer. 2002 Jun;34(2):186-92. doi: 10.1002/gcc.10055. Genes Chromosomes Cancer. 2002. PMID: 11979552

2

dic(5;17): a recurring abnormality in malignant myeloid disorders associated with mutations of TP53.

Wang P, Spielberger RT, Thangavelu M, Zhao N, Davis EM, Iannantuoni K, Larson RA, Le Beau MM. Wang P, et al. Among authors: le beau mm. Genes Chromosomes Cancer. 1997 Nov;20(3):282-91. doi: 10.1002/(sici)1098-2264(199711)20:3<282::aid-gcc9>3.0.co;2-z. Genes Chromosomes Cancer. 1997. PMID: 9365836

3

RAS, FLT3, and TP53 mutations in therapy-related myeloid malignancies with abnormalities of chromosomes 5 and 7.

Side LE, Curtiss NP, Teel K, Kratz C, Wang PW, Larson RA, Le Beau MM, Shannon KM. Side LE, et al. Among authors: le beau mm. Genes Chromosomes Cancer. 2004 Mar;39(3):217-23. doi: 10.1002/gcc.10320. Genes Chromosomes Cancer. 2004. PMID: 14732923

4

Therapy-related myeloid leukaemia: a model for leukemogenesis in humans.

Larson RA, Le Beau MM. Larson RA, et al. Among authors: le beau mm. Chem Biol Interact. 2005 May 30;153-154:187-95. doi: 10.1016/j.cbi.2005.03.023. Epub 2005 Apr 13. Chem Biol Interact. 2005. PMID: 15935816

5

Clinical, morphologic, and cytogenetic characteristics of patients with lymphoid malignancies characterized by both t(14;18)(q32;q21) and t(8;14)(q24;q32) or t(8;22)(q24;q11).

Thangavelu M, Olopade O, Beckman E, Vardiman JW, Larson RA, McKeithan TW, Le Beau MM, Rowley JD. Thangavelu M, et al. Among authors: le beau mm. Genes Chromosomes Cancer. 1990 Jul;2(2):147-58. doi: 10.1002/gcc.2870020211. Genes Chromosomes Cancer. 1990. PMID: 2278969

6

An (8;14)(q24;q11) translocation involving the T-cell receptor alpha-chain gene and the MYC oncogene 3' region in a B-cell lymphoma.

Park JK, McKeithan TW, Le Beau MM, Bitter MA, Franklin WA, Rowley JD, Diaz MO. Park JK, et al. Among authors: le beau mm. Genes Chromosomes Cancer. 1989 Sep;1(1):15-22. doi: 10.1002/gcc.2870010105. Genes Chromosomes Cancer. 1989. PMID: 2535034

7

Der(5)t(5;7)(q11.2;p11.2): a new recurring abnormality in malignant myeloid disorders.

Thangavelu M, Bitter MA, Larson RA, Davis EM, Rowley JD, Le Beau MM. Thangavelu M, et al. Among authors: le beau mm. Cancer Genet Cytogenet. 1989 Jan;37(1):1-8. doi: 10.1016/0165-4608(89)90067-8. Cancer Genet Cytogenet. 1989. PMID: 2917326

8

Analysis of deletions of the long arm of chromosome 11 in hematologic malignancies with fluorescence in situ hybridization.

Kobayashi H, Espinosa R 3rd, Fernald AA, Begy C, Diaz MO, Le Beau MM, Rowley JD. Kobayashi H, et al. Among authors: le beau mm. Genes Chromosomes Cancer. 1993 Dec;8(4):246-52. doi: 10.1002/gcc.2870080407. Genes Chromosomes Cancer. 1993. PMID: 7512368

9

Do terminal deletions of 11q23 exist? Identification of undetected translocations with fluorescence in situ hybridization.

Kobayashi H, Espinosa R 3rd, Thirman MJ, Fernald AA, Shannon K, Diaz MO, Le Beau MM, Rowley JD. Kobayashi H, et al. Among authors: le beau mm. Genes Chromosomes Cancer. 1993 Aug;7(4):204-8. doi: 10.1002/gcc.2870070404. Genes Chromosomes Cancer. 1993. PMID: 7692945

10

The relationship between secondary chromosomal abnormalities and blast transformation in chronic myelogenous leukemia.

Anastasi J, Feng J, Le Beau MM, Larson RA, Rowley JD, Vardiman JW. Anastasi J, et al. Among authors: le beau mm. Leukemia. 1995 Apr;9(4):628-33. Leukemia. 1995. PMID: 7723396

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

483 results

Search Page

Filters